Please login to the form below

Not currently logged in

Novo Nordisk acquires two US biopharma companies

Novo Nordisk headquarters

Strikes deals with Calibrium LLC and MB2

Alnylam predicts big things for its PCSK9 inhibitor ALN-PCS

AlnylamGene silencing specialist says its early-stage candidate has blockbuster potential

Bayer moves heart failure candidate finerenone into phase III

Bayer symbolFollows positive phase IIb data presented at the European Society of Cardiology (ESC) meeting

Roche wins first approval for skin cancer drug Cotellic

Switzerland flagSwiss regulators give the Exelixis-discovered treatment the green light

GCI Health expands into medical education

GCI Health Cally Clarkson medical educationComms agency appoints Cally Clarkson to lead its new offering in the area

NICE recommends Daiichi Sankyo's Lixiana for DVT and PE

Daiichi Sankyo logoInstitute's final guidance concludes the novel oral anticoagulant is cost effective

FDA follows WHO lead on biosimilar naming

FDA headquarters White OakProposes adding suffixes to distinguish biosimilar drug names

FDA clears Jardiance combo for type 2 diabetes

Lilly Boehringer diabetes collaborationCombination treatment Synjardy is fifth drug to come from Boehringer/Lilly diabetes alliance

Amgen wins FDA approval for cholesterol drug Repatha

Amgen Repatha evolocumabWill give it a quick launch in the US to catch-up with Sanofi's Praluent

Oncology directions

With increasingly expensive cancer drugs, what price should be paid for innovation?

Latest appointments

Featured jobs

Subscribe to our email news alerts


Add my company

THE SCIENCE BEHIND CREATIVE RESULTS When science meets art there's chemistry. We simply add passion, positivity and a human warmth....

Latest intelligence

Competition from within
Published in eyeforpharma July 29 by Rachel Howard...
Infographic: RA Perceptions
HCPs predict the future of the biologics market...
From chaos to calm: how to make sense of social media
What do you know about chaos theory?...